16913

    542919

    ARTEMISMED

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    ARTEMIS MED SERVICE LTD Share Price Today

    ARTEMIS MED SERVICE LTD is currently trading at ₹265.1, up by ₹2.5 from the previous close. The stock touched an intraday high of ₹267.45 and a low of ₹261.15 during the latest trading session. Over the past one year, ARTEMIS MED SERVICE LTD has delivered a return of 5.62%, while the stock has declined 9.31% in the last one month.

    ARTEMIS MED SERVICE LTD performance

    Today’s low Today’s high
    ₹ 261.15 ₹ 267.45
    ₹ 265.85
    52 week low 52 week high
    ₹ 203.35 ₹ 297.50
    ₹ 265.85
    Open Price ₹ 261.15
    Prev. Close ₹ 262.60
    Volume (Shares) 21187.00
    Total traded value ₹ 56.32
    Upper Circuit ₹ 315.10
    Lower Circuit ₹ 210.10
    info

    Investment Returns

    Over 1 Month -9.31% Over 3 Months 15.68% Over 6 Months -5.14% Over 1 Year 5.62%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    ARTEMIS MED SERVICE LTD fundamentals


    • Market cap (Cr) 4,215.70
    • P/E Ratio (TTM) 40.21
    • Beta 0.73
    • Book Value / share 54.96
    • Return on equity 14.43%
    • EPS (TTM) 6.68
    • Dividend yield 0.17%
    • Net profit/quarter (Cr) 29.55
    info icon alternate text
    • Market cap (Cr) 4,170.60
    • P/E Ratio (TTM) 40.21
    • Beta 0.68
    • Book Value / share 54.96
    • Return on equity 14.43%
    • EPS (TTM) 6.68
    • Dividend yield 0.17%
    • Net profit/quarter (Cr) 29.55
    info icon alternate text

    ARTEMIS MED SERVICE LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 273.79
    Operating Expense 242.19
    Net Profit 29.55
    Net Profit Margin (%) 10.79
    Earnings Per Share (EPS) 1.87
    EBITDA 57.97
    Effective Tax Rate (%) 24.77
    Particulars DEC 2025 (Values in Cr)
    Revenue 267.12
    Operating Expense 241.96
    Net Profit 22.51
    Net Profit Margin (%) 8.42
    Earnings Per Share (EPS) 1.42
    EBITDA 48.20
    Effective Tax Rate (%) 23.87
    Particulars SEP 2025 (Values in Cr)
    Revenue 269.78
    Operating Expense 237.79
    Net Profit 29.96
    Net Profit Margin (%) 11.10
    Earnings Per Share (EPS) 1.90
    EBITDA 57.94
    Effective Tax Rate (%) 24.64
    Particulars JUN 2025 (Values in Cr)
    Revenue 249.80
    Operating Expense 226.69
    Net Profit 21.42
    Net Profit Margin (%) 8.57
    Earnings Per Share (EPS) 1.36
    EBITDA 47.84
    Effective Tax Rate (%) 28.76
    Particulars MAR 2025 (Values in Cr)
    Revenue 234.80
    Operating Expense 218.04
    Net Profit 23.20
    Net Profit Margin (%) 9.88
    Earnings Per Share (EPS) 1.48
    EBITDA 47.78
    Effective Tax Rate (%) 19.96
    Particulars MAR 2026 (Values in Cr)
    Revenue 1060.49
    Operating Expense 948.63
    Net Profit 103.44
    Net Profit Margin (%) 9.75
    Earnings Per Share (EPS) 6.55
    EBITDA 211.95
    Effective Tax Rate (%) 25.41
    Particulars MAR 2025 (Values in Cr)
    Revenue 913.26
    Operating Expense 836.92
    Net Profit 83.46
    Net Profit Margin (%) 9.13
    Earnings Per Share (EPS) 5.42
    EBITDA 182.75
    Effective Tax Rate (%) 23.61
    Particulars MAR 2024 (Values in Cr)
    Revenue 845.23
    Operating Expense 784.47
    Net Profit 49.15
    Net Profit Margin (%) 5.81
    Earnings Per Share (EPS) 3.62
    EBITDA 135.66
    Effective Tax Rate (%) 27.76
    Particulars MAR 2023 (Values in Cr)
    Revenue 714.33
    Operating Expense 668.60
    Net Profit 39.69
    Net Profit Margin (%) 5.55
    Earnings Per Share (EPS) 2.98
    EBITDA 100.92
    Effective Tax Rate (%) 24.93
    Particulars MAR 2022 (Values in Cr)
    Revenue 544.78
    Operating Expense 509.86
    Net Profit 32.58
    Net Profit Margin (%) 5.98
    Earnings Per Share (EPS) 2.46
    EBITDA 71.06
    Effective Tax Rate (%) 16.05
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 55.90
    ROE % 14.30
    ROCE % 15.66
    Total Debt to Total Equity 0.53
    EBITDA Margin 19.72
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 28.00
    ROE % 13.72
    ROCE % 14.87
    Total Debt to Total Equity 0.85
    EBITDA Margin 15.94
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 25.03
    ROE % 12.10
    ROCE % 12.41
    Total Debt to Total Equity 0.78
    EBITDA Margin 13.74
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 22.10
    ROE % 11.50
    ROCE % 10.81
    Total Debt to Total Equity 0.64
    EBITDA Margin 12.86
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 191.73
    ROE % 2.33
    ROCE % 4.51
    Total Debt to Total Equity 0.52
    EBITDA Margin 9.54
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 56.20
    ROE % 14.43
    ROCE % 15.83
    Total Debt to Total Equity 0.51
    EBITDA Margin 20.01
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 28.24
    ROE % 13.60
    ROCE % 14.85
    Total Debt to Total Equity 0.79
    EBITDA Margin 16.05
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 25.28
    ROE % 12.53
    ROCE % 12.88
    Total Debt to Total Equity 0.72
    EBITDA Margin 14.13
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 22.26
    ROE % 11.85
    ROCE % 11.20
    Total Debt to Total Equity 0.60
    EBITDA Margin 13.04
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 192.81
    ROE % 2.52
    ROCE % 4.77
    Total Debt to Total Equity 0.49
    EBITDA Margin 9.65
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 395.53
    Total Assets 1357.40
    Total Liabilities 1357.40
    Total Equity 843.55
    Share Outstanding 13
    Price to Book Ratio 4.89
    Return on Assets (%) 6.08
    Return on Capital (%) 7.58
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 61.34
    Total Assets 971.51
    Total Liabilities 971.51
    Total Equity 454.68
    Share Outstanding 13
    Price to Book Ratio 6.01
    Return on Assets (%) 5.05
    Return on Capital (%) 6.94
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 50.94
    Total Assets 904.95
    Total Liabilities 904.95
    Total Equity 407.68
    Share Outstanding 13
    Price to Book Ratio 2.69
    Return on Assets (%) 4.26
    Return on Capital (%) 5.95
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 27.69
    Total Assets 709.66
    Total Liabilities 709.66
    Total Equity 361.26
    Share Outstanding 13
    Price to Book Ratio 2.06
    Return on Assets (%) 4.48
    Return on Capital (%) 5.84
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 31.11
    Total Assets 600.08
    Total Liabilities 600.08
    Total Equity 321.74
    Share Outstanding 1
    Price to Book Ratio 1.15
    Return on Assets (%) 1.08
    Return on Capital (%) 1.51
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 393.26
    Total Assets 1343.10
    Total Liabilities 1343.10
    Total Equity 841.79
    Share Outstanding 13
    Price to Book Ratio 4.89
    Return on Assets (%) 6.21
    Return on Capital (%) 7.74
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 57.93
    Total Assets 948.03
    Total Liabilities 948.03
    Total Equity 451.63
    Share Outstanding 13
    Price to Book Ratio 6.01
    Return on Assets (%) 5.18
    Return on Capital (%) 7.12
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 48.32
    Total Assets 881.83
    Total Liabilities 881.83
    Total Equity 406.42
    Share Outstanding 13
    Price to Book Ratio 2.69
    Return on Assets (%) 4.50
    Return on Capital (%) 6.3
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 27.11
    Total Assets 697.40
    Total Liabilities 697.40
    Total Equity 361.61
    Share Outstanding 13
    Price to Book Ratio 2.06
    Return on Assets (%) 4.67
    Return on Capital (%) 6.1
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 28.84
    Total Assets 588.95
    Total Liabilities 588.95
    Total Equity 321.62
    Share Outstanding 1
    Price to Book Ratio 1.15
    Return on Assets (%) 1.20
    Return on Capital (%) 1.61
    Particulars MAR 2025 (Values in Cr)
    Net Income 107.66
    Cash from Operations 159.46
    Cash from Investing -385.38
    Cash from Financing 266.74
    Net change in Cash 26.97
    Free Cash Flow 252.61
    Particulars MAR 2024 (Values in Cr)
    Net Income 68.45
    Cash from Operations 124.45
    Cash from Investing -88.13
    Cash from Financing -28.97
    Net change in Cash -8.25
    Free Cash Flow 197.00
    Particulars MAR 2023 (Values in Cr)
    Net Income 50.60
    Cash from Operations 130.03
    Cash from Investing -158.21
    Cash from Financing 38.22
    Net change in Cash 7.16
    Free Cash Flow 276.50
    Particulars MAR 2022 (Values in Cr)
    Net Income 37.18
    Cash from Operations 42.82
    Cash from Investing -107.22
    Cash from Financing 44.22
    Net change in Cash -3.46
    Free Cash Flow 151.73
    Particulars MAR 2021 (Values in Cr)
    Net Income 7.53
    Cash from Operations 25.12
    Cash from Investing -37.42
    Cash from Financing 17.71
    Net change in Cash 7.55
    Free Cash Flow 59.62
    Particulars MAR 2025 (Values in Cr)
    Net Income 109.25
    Cash from Operations 153.09
    Cash from Investing -388.28
    Cash from Financing 276.95
    Net change in Cash 27.75
    Free Cash Flow 246.08
    Particulars MAR 2024 (Values in Cr)
    Net Income 68.04
    Cash from Operations 121.94
    Cash from Investing -89.90
    Cash from Financing -26.09
    Net change in Cash -8.41
    Free Cash Flow 193.74
    Particulars MAR 2023 (Values in Cr)
    Net Income 52.86
    Cash from Operations 131.80
    Cash from Investing -152.53
    Cash from Financing 29.73
    Net change in Cash 6.55
    Free Cash Flow 267.67
    Particulars MAR 2022 (Values in Cr)
    Net Income 38.80
    Cash from Operations 76.99
    Cash from Investing -106.09
    Cash from Financing 43.65
    Net change in Cash -1.77
    Free Cash Flow 183.53
    Particulars MAR 2021 (Values in Cr)
    Net Income 8.90
    Cash from Operations 29.41
    Cash from Investing -34.07
    Cash from Financing 12.72
    Net change in Cash 5.69
    Free Cash Flow 57.68
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8593.25 63.16 13.04 123557.75 6680.00 8692.00
    FORTIS MALAR HOSPITALS LIMITED 52.42 23.72 2.86 98.24 40.75 76.00
    SHREE PACETRONIX LTD. 130.05 15.52 2.73 48.76 66.10 283.15
    TRANSGENE BIOTEK LTD. 3.11 0.00 2.81 23.56 1.83 5.26
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8593.25 82.30 12.40 123557.75 6680.00 8692.00
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 39.60 0.00 -9.63 29.58 30.30 57.48
    KOVAI MEDICAL CENTER & HO 6020.65 26.94 4.99 6586.59 5010.00 6725.00

    ARTEMIS MED SERVICE LTD shareholding pattern

    Holding
    26.52%
    58.39%
    12.19%
    2.88%
    44.53%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    ARTEMIS MED SERVICE LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    266.30 1.40 redarrow
    red-green-graph indicator
    1 Bearish
    15 Bullish
    • 5 Days 263.10
    • 26 Days 263.50
    • 10 Days 263.20
    • 50 Days 259.50
    • 12 Days 263.40
    • 100 Days 254.20
    • 20 Days 263.90
    • 200 Days 252.60
    262.18 PIVOT
    First Support 258.42 First Resistance 264.87 Second Support 255.73 Second Resistance 268.63 Third Support 251.97 Third Resistance 271.32
    RSI 47.74 ADX 10.38 MACD -0.05 Williams % R -67.62 Commodity Channel Index (CCI) -39.87
    Date 2026-06-25 Week 96150.00 Same Day 49627.00 Month 90997.00
    1 Year 0.74 3 Year 0.82
    Over 1 Month
    -9.31% down
    Over 1 Year
    5.62% down
    Over 3 Months
    15.68% down
    Over 3 Years
    26.54% down
    Over 6 Months
    -5.14% down
    Over 5 Years
    54.24% down

    ARTEMIS MED SERVICE LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    10 Jul 2026 0.45 Final 10 Jul 2026 Equity shares
    11 Jul 2025 0.45 Final 11 Jul 2025 Equity shares
    05 Jul 2024 0.45 Final 05 Jul 2024 Equity shares
    14 Jul 2023 0.45 Final 14 Jul 2023 Equity shares
    Ex-Date Old FV NEW FV Record Date
    23 Sep 2021 10.0 1.0 24 Sep 2021
    Dividend date Dividend amount Dividend type Record date Instrument type
    10 Jul 2026 0.45 Final 10 Jul 2026 Equity shares
    11 Jul 2025 0.45 Final 11 Jul 2025 Equity shares
    05 Jul 2024 0.45 Final 05 Jul 2024 Equity shares
    14 Jul 2023 0.45 Final 14 Jul 2023 Equity shares
    Ex-Date Old FV NEW FV Record Date
    23 Sep 2021 10.0 1.0 24 Sep 2021

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Artemis Medicare Services Ltd?

    Answer Field

    Artemis Medicare Services Ltd share price is for NSE ₹ 265.10 & for BSE ₹ 265.45 as on Jun 30 2026 10:52 AM.

    What is the Market Cap of Artemis Medicare Services Ltd Share?

    Answer Field

    The market cap of Artemis Medicare Services Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 30 2026 10:52 AM.

    What is the 52 Week High and Low of Artemis Medicare Services Ltd?

    Answer Field

    The 52 Week High and Low of Artemis Medicare Services Ltd for NSE is ₹ 297.50 and ₹ 203.35 and for BSE is ₹ 297.70 and ₹ 202.85.

    What is 1 year return for Artemis Medicare Services Ltd?

    Answer Field

    The 1 year returns on the stock has been 3.18%.

    What is the P/E Ratio of Artemis Medicare Services Ltd Share?

    Answer Field

    As on Jun 30 2026 10:52 AM the price-to-earnings (PE) ratio for Artemis Medicare Services Ltd share is 40.21.

    What is the PB ratio of Artemis Medicare Services Ltd Share?

    Answer Field

    As on Jun 30 2026 10:52 AM, the price-to-book (PB) ratio for Artemis Medicare Services Ltd share is 54.96.

    How to Buy Artemis Medicare Services Ltd Share?

    Answer Field

    You can trade in Artemis Medicare Services Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Artemis Medicare Services Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Artemis Medicare Services Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Artemis Medicare Services Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |